Media Releases

Stay updated on our latest innovations and activities as we bring new technologies from Singapore to the world.

Mirxes Announces NMPA Approval for GASTROClear™ in China, Paving the Way for Major Launch in Key Market
09 October 2025
Mirxes Joins Prestigious Hang Seng Composite Index, Bolstering Market Position and Access to Key Investors
25 August 2025
Former Japanese PM Yukio Hatoyama Launches Nationwide Gastric Health Initiative with Mirxes’ GASTROClear™
25 July 2025
Mirxes Soars as Southeast Asia’s First Biotech Unicorn, Following Blistering HKEX Debut
23 May 2025
Global Offering
15 May 2025
Mirxes Announces US$40M Synthetic Royalty-Backed Financing from CBC Group’s R-Bridge to Accelerate Global Growth
13 January 2025
Mirxes and Canhelp Genomics Partner to Advance Cancer Diagnostic in Singapore and the Region
11 November 2024
Mirxes Japan Scores Grant to Develop Novel Cancer Screening Test in Japan
11 July 2024
Mirxes and PULSE TCM Launches Holistic “East Meets West” Community Health Screening Pilot
24 May 2024
Official Opening of Singapore’s Pioneering Public-Private Partnership Centre for Specialty Molecular Testing
13 May 2024
Mirxes receives FDA’s Breakthrough Device Designation for GASTROClear to advance blood-based cancer early detection
10 August 2023
Mirxes secures US$50 Million in Series D funding and files listing application with The Stock Exchange of Hong Kong Limited
26 July 2023

Investor Relations
Investor Relations